PHLDB3 and malignant colon neoplasm: As anticipated above (Fig. 3), PHLDB3 silencing led to marked reduction of colon cancer cell viability, which was more significant in HCT116p53+/+ cells (Fig. 4i) than in HCT116p53−/− cells (Fig. 4h).